Yes some patients with mTNBC were very sick , but some like from our Ph 1b/2 trial , it was a trial for treatment naive patients , newly diagnosed , not severely sick yet , it was 10 patients from this trial.

I can say one thing for sure ,
If patients with severe problems are undertreated , or drug is given to late , many will die needlessly ,

And that's what will happen here , as it happened in our CD12.